| Literature DB >> 29059178 |
Maren S Fragala1, Caixia Bi1, Michael Chaump1, Harvey W Kaufman1, Martin H Kroll1.
Abstract
OBJECTIVES: Physical exercise may affect levels of blood-based biomarkers. However, exercise status is seldom considered in the interpretation of laboratory results. This study reports the associations between habitual exercise participation and clinical laboratory test results.Entities:
Mesh:
Year: 2017 PMID: 29059178 PMCID: PMC5653181 DOI: 10.1371/journal.pone.0180840
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Prevalence of medical conditions (by self-report).
| Condition | Number | % |
|---|---|---|
| Allergy | 25,336 | 31.6 |
| Anemia | 5,659 | 7.1 |
| Arthritis | 1,774 | 2.2 |
| Asthma | 8,172 | 10.2 |
| Cancer | 506 | 0.6 |
| Diabetes | 2,044 | 2.6 |
| Cardiovascular | 4,135 | 5.2 |
| Hypertension | 4,066 | 5.1 |
| Liver | 184 | 0.2 |
| Renal | 240 | 0.3 |
| Thyroid | 3,205 | 4.0 |
Fig 1Cumulative distribution of biomarkers for 0 and 5+ days of aerobic (A) or/and strength (S) exercise participation among men and women aged 18–34 years.
Fig 4Cumulative distribution of biomarkers for 0 and 5+ days of aerobic (A) or/and strength (S) exercise participation among men and women aged 18–34 years.
Multivariate regression for the effect of aerobic and strength exercise participation on biomarker levels in women and men aged 18–34 years.
Sample size varied by marker, ranging from 27,715 to 45,725 for women and 14,384 to 34,325 for men. ap<0.05; bp<0.01 . Italics indicate not statistically significant.
| Women | Men | |||||||
|---|---|---|---|---|---|---|---|---|
| Test | (Intercept) | Aerobic (x1) | Strength (x2) | R2 | (Intercept) | Aerobic (x1) | Strength (x2) | R2 |
| A1C | 5.46 | -0.0253b | -0.0075b | 0.89 | 5.49 | -0.0236b | -0.0082a | 0.8 |
| AGratio | 1.57 | 0.0186 b | 0.0078b | 0.92 | 1.80 | 0.0173b | 0.71 | |
| ALB | 4.37 | 0.0062b | 0.0133b | 0.78 | 4.70 | 0.0086b | 0.34 | |
| ALP | 65.48 | -1.0724b | -0.938b | 0.86 | 69.07 | -0.7420b | 0.55 | |
| ALT | 16.95 | -0.1794b | 0.37 | 32.05 | -1.0864b | -0.3121b | 0.82 | |
| AST | 17.21 | 0.1513b | 0.2059b | 0.68 | 23.02 | -0.2346b | 0.5101a | 0.5 |
| BILItot | 0.52 | 0.0122b | 0.0075b | 0.83 | 0.70 | 0.0167b | 0.61 | |
| CA | 9.35 | 0.0061 a | 0.0119b | 0.73 | 9.65 | 0.011b | 0.44 | |
| cCRP | 4.60 | -0.1928b | -0.2517b | 0.87 | 2.57 | -0.0957b | -0.1597b | 0.8 |
| CHOL | 177.77 | -0.9137a | 0.56 | 184.50 | -0.5150b | -1.6370b | 0.86 | |
| CREA | 0.72 | 0.0096b | 0.0073b | 0.91 | 0.98 | 0.0033a | 0.0113b | 0.8 |
| EGFR | 110.07 | -1.1619b | -0.8565b | 0.9 | 103.67 | -0.4502a | -0.8949b | 0.72 |
| FER | 46.62 | 0.05 | 182.75 | -6.646b | 0.61 | |||
| GGT | 19.99 | -0.4522b | -0.2102a | 0.71 | 35.15 | -1.1238b | -1.0039b | 0.8 |
| GLOB | 2.84 | -0.0312b | 0.89 | 2.66 | -0.0206b | 0.67 | ||
| GLUC | 87.84 | -0.3543b | -0.3042b | 0.88 | 92.66 | -0.2924b | -0.5338b | 0.8 |
| HDL | 55.44 | 1.352b | 0.5797b | 0.91 | 44.22 | 0.9524b | 0.7206b | 0.94 |
| HDLratio | 3.38 | -0.0663b | -0.0522b | 0.93 | 4.43 | -0.0981b | -0.0926b | 0.95 |
| IBC | 370.68 | 0.058 | 333.36 | -0.4295a | -0.5278a | 0.48 | ||
| IRON | 84.08 | 2.602b | 1.0756b | 0.83 | 102.64 | 0.6744a | 0.6371a | 0.53 |
| LDL | 100.82 | -0.6472b | -1.186b | 0.85 | 110.03 | -0.3805a | -1.3404b | 0.86 |
| pctSat | 23.57 | 0.6684b | 0.3202b | 0.83 | 31.27 | 0.2454b | 0.256b | 0.62 |
| PROT | 7.21 | -0.0222b | 0.0087b | 0.66 | 7.36 | -0.0125b | 0.33 | |
| TRIG | 107.58 | -1.8552b | -2.7041b | 0.93 | 158.00 | -6.0483b | -5.5925b | 0.92 |
| TSH | 2.01 | 0.079 | 2.03 | 0.05 | ||||
| Urate | 4.65 | 0.157 | 6.67 | -0.0301b | -0.0523 b | 0.75 | ||
Fig 10Average biomarker levels for 0 to 5+ days of aerobic or/and strength exercise participation for women.
Reference intervals and predicted values for 0 and 5+ days of aerobic or strength exercise participation per week in men and women aged 18–34 years.
| Women | Men | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test | Unit | Reference Interval | Estimate 0 days | Aerobic 5 days | Strength 5 days | Both 5 days | Reference Interval | Estimate 0 days | Aerobic 5 days | Strength 5 days | Both 5 days | ||||
| A1C | % | - | - | 5.7 | 5.5 | 5.3 | 5.4 | 5.3 | - | 5.7 | 5.5 | 5.4 | 5.4 | 5.3 | |
| AGratio | 1 | - | 2.5 | 1.6 | 1.7 | 1.6 | 1.7 | 1 | - | 2.5 | 1.8 | 1.9 | 1.8 | 1.9 | |
| ALB | g/dL | 3.6 | - | 5.1 | 4.4 | 4.4 | 4.4 | 4.5 | 3.6 | - | 5.1 | 4.7 | 4.7 | 4.7 | 4.7 |
| ALP | U/L | 33 | - | 115 | 65.5 | 60.1 | 60.8 | 55.4 | 40 | - | 115 | 69.1 | 65.4 | 69.1 | 65.4 |
| ALT | U/L | 6 | - | 29 | 16.9 | 16.0 | 16.9 | 16.0 | 9 | - | 46 | 32.0 | 26.6 | 30.5 | 25.1 |
| AST | U/L | 10 | - | 35 | 17.2 | 18.0 | 18.2 | 19.0 | 10 | - | 40 | 23.0 | 21.8 | 25.6 | 24.4 |
| BILItot | mg/dL | 0.2 | - | 1.2 | 0.5 | 0.6 | 0.6 | 0.6 | 0.2 | - | 1.2 | 0.7 | 0.8 | 0.7 | 0.8 |
| CA | mg/dL | 8.6 | - | 10.2 | 9.4 | 9.4 | 9.4 | 9.4 | 8.6 | - | 10.3 | 9.6 | 9.7 | 9.6 | 9.7 |
| cCRP | mg/dL | 0 | - | 3 | 4.6 | 3.6 | 3.3 | 2.4 | 0 | - | 3 | 2.6 | 2.1 | 1.8 | 1.3 |
| CHOL | mg/dL | 125 | - | 200 | 177.8 | 173.2 | 177.8 | 173.2 | 125 | - | 200 | 184.5 | 181.9 | 176.3 | 173.7 |
| CREA | mg/dL | 0.5 | - | 1.1 | 0.7 | 0.8 | 0.8 | 0.8 | 0.6 | - | 1.35 | 1.0 | 1.0 | 1.0 | 1.1 |
| EGFR | mL/min/ | 90 | - | - | 110.1 | 104.3 | 105.8 | 100.0 | 90 | - | - | 103.7 | 101.4 | 99.2 | 96.9 |
| FER | ng/mL | 10 | - | 154 | - | - | - | - | 20 | - | 345 | 182.7 | 149.5 | 182.7 | 149.5 |
| GGT | U/L | 3 | - | 40 | 20.0 | 17.7 | 18.9 | 16.7 | 3 | - | 70 | 35.2 | 29.5 | 30.1 | 24.5 |
| GLOB | g/dL | 1.9 | - | 3.7 | 2.8 | 2.7 | 2.8 | 2.7 | 1.9 | - | 3.7 | 2.7 | 2.6 | 2.7 | 2.6 |
| GLUC | mg/dL | 65 | - | 99 | 87.8 | 86.1 | 86.3 | 84.5 | 65 | - | 99 | 92.7 | 91.2 | 90.0 | 88.5 |
| HDL | mg/dL | 46 | - | 55.4 | 62.2 | 58.3 | 65.1 | 40 | - | 44.2 | 49.0 | 47.8 | 52.6 | ||
| HDLratio | ratio | - | - | 5 | 3.4 | 3.0 | 3.1 | 2.8 | - | 5 | 4.4 | 3.9 | 4.0 | 3.5 | |
| IBC | mcg/dL | 250 | - | 450 | - | - | - | - | 250 | - | 425 | 333.4 | 331.2 | 330.7 | 328.6 |
| IRON | mcg/dL | 40 | - | 190 | 84.1 | 97.1 | 89.5 | 102.5 | 50 | - | 195 | 102.6 | 106.0 | 105.8 | 109.2 |
| LDL | mg/dL | - | - | 130 | 100.8 | 97.6 | 94.9 | 91.7 | - | 130 | 110.0 | 108.1 | 103.3 | 101.4 | |
| pctSat | % | 11 | - | 50 | 23.6 | 26.9 | 25.2 | 28.5 | 15 | - | 60 | 31.3 | 32.5 | 32.5 | 33.8 |
| PROT | g/dL | 6.1 | - | 8.1 | 7.2 | 7.1 | 7.3 | 7.1 | 6.1 | - | 8.1 | 7.4 | 7.4 | 7.3 | 7.3 |
| TRIG | mg/dL | - | - | 150 | 107.6 | 98.3 | 94.1 | 84.8 | - | 150 | 158.0 | 127.8 | 130.0 | 99.8 | |
| TSH | mIU/L | 0.4 | - | 5 | - | - | - | - | - | - | - | - | - | - | |
| Urate | mg/dL | 2.5 | - | 7 | - | - | - | - | 4 | - | 8 | 6.7 | 6.5 | 6.4 | 6.3 |